Propiedad y actividad de insiders de Tenaya Therapeutics, Inc. (TNYA): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.66 |
| Capitalización | $143M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $23.9M | $128.5M | $38.1M | $95.3M | $45.7M | $4.3M | $100.5M |
| Inversiones a Corto | $2.8M | 0 | $213.2M | $91.3M | $59.0M | $57.1M | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | $2.2M | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $27.7M | $130.0M | $255.4M | $193.8M | $111.6M | $67.4M | $105.6M |
| Inmovilizado Material | $9.6M | $17.2M | $54.7M | $62.7M | $53.3M | $47.7M | $37.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $38.0M | $148.2M | $316.6M | $278.9M | $170.5M | $119.9M | $146.9M |
| Cuentas por Pagar | $600000 | $1.0M | $10.7M | $9.6M | $5.6M | $5.2M | $3.6M |
| Deuda a Corto | 0 | 0 | $2.0M | 0 | 0 | $2.8M | 0 |
| Pasivos Corrientes | $4.1M | $5.0M | $21.8M | $24.2M | $22.7M | $16.0M | $15.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | $7.8M |
| Pasivos Totales | $81.7M | $8.7M | $38.1M | $35.6M | $31.1M | $27.1M | $23.7M |
| Reservas | -$44.4M | -$82.8M | -$155.5M | -$279.2M | -$403.3M | -$514.4M | -$605.0M |
| Patrimonio Neto | -$43.7M | $139.4M | $278.5M | $243.4M | $139.4M | $92.9M | $123.3M |
| Deuda Total | 0 | 0 | $15.7M | $15.1M | $12.4M | $13.6M | $10.8M |
| Deuda Neta | -$26.6M | -$128.5M | -$235.6M | -$171.4M | -$92.2M | -$47.8M | -$89.7M |
| Capital Circulante | $23.6M | $124.9M | $233.6M | $169.5M | $88.8M | $51.4M | $90.2M |
Salud financiera
| Deuda / Patrimonio | 0.06 |
| Ratio corriente | 4.52 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -4.36 |
Rentabilidad
| Rentabilidad sobre capital | -108.05% |
| Rentabilidad sobre capital invertido | -136.78% |
| Rentabilidad sobre activos | -110.24% |
| Margen bruto | 263.67% |
| Margen operativo | -7929.89% |
| Margen neto | -7723.97% |
Empresas relacionadas: ABEO · CRBU · ENTA · FHTX · HUMA · IMRX · NAUT
Explorar sector: Healthcare · Biotechnology
Más secciones de TNYA: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones